Document Detail

Emerging drugs for gastro-oesophageal reflux disease.
MedLine Citation:
PMID:  15934879     Owner:  NLM     Status:  MEDLINE    
Gastro-oesophageal reflux disease is a common medical problem caused by the exposure of the distal oesophagus to gastric contents. Existing medical therapy is very effective, but symptomatic relief with acid suppressants is often delayed. Treatment focuses on the suppression of gastric acid rather than on the underlying pathophysiological abnormalities, such as transient non-swallow-related lower oesophageal sphincter relaxation. Current pharmacological developments concentrate on drugs with lasting acid suppression and a faster onset of action. Compounds interacting with the complex neuromuscular regulation of the gastro-oesophageal junction are also being developed and offer exciting prospects.
Peter Wurm; John De Caestecker
Related Documents :
9428869 - Alterations in the course of acid-induced lung injury in rats after general anesthesia:...
18951509 - The source of carbon dioxide for gastric acid production.
6869679 - Proximal gastric vagotomy interferes with a fundic inhibitory mechanism. a hypothesis f...
15828939 - Multiple fragments related to angiostatin and endostatin in fluid from venous leg ulcers.
3916579 - Histamine and the gut.
17101299 - Validation of a new endoscopic technique to assess acid output in zollinger-ellison syn...
15963369 - Acid neutralization within limestone sand reactors receiving coal mine drainage.
16740499 - Comparison of bean biochemical composition and beverage quality of arabica hybrids invo...
372609 - Ticrynafen and hydrochlorothiazide. a double-blind study of antihypertensive properties...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Expert opinion on emerging drugs     Volume:  10     ISSN:  1744-7623     ISO Abbreviation:  Expert Opin Emerg Drugs     Publication Date:  2005 May 
Date Detail:
Created Date:  2005-06-06     Completed Date:  2006-04-14     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  101135662     Medline TA:  Expert Opin Emerg Drugs     Country:  England    
Other Details:
Languages:  eng     Pagination:  457-71     Citation Subset:  IM    
Digestive Diseases Centre, University Hospitals of Leicester, Leicester, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antacids / chemistry,  therapeutic use
Clinical Trials as Topic / statistics & numerical data
Drug Industry / trends*
Drugs, Investigational / chemistry,  therapeutic use*
Gastroesophageal Reflux / drug therapy*,  physiopathology
Gastrointestinal Agents / chemistry,  therapeutic use*
Reg. No./Substance:
0/Antacids; 0/Drugs, Investigational; 0/Gastrointestinal Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Current and future pharmacological intervention for diabetic retinopathy.
Next Document:  Adjunctive strategies in the treatment of refractory bipolar depression: clinician options in the ab...